Member Profile: Nie Rakovine
They started their work as an EuropaColon Slovakia in May 2007, as independent and nonprofit organization for patients with colorectal carcinoma as a part of DiCE (former Europacolon). Epidemiological data for cancer and years of experiences with patients motivate them to spread their target and joined “European Pancreatic Cancer Multi-Stakeholders Platform” in 2014. Two years later the founders of “EuropaColon Slovakia” established a new alliance “No to cancer Slovakia” on November 17, 2016 — the World Pancreatic Cancer Awareness Day.
Their mission is to spread awareness and brink the evidence-based facts about prevention and benefits of early detection. Providing peer to peer counseling through trained volunteers. They are lobbying for patents rights, availability of diagnostics and new treatment for patients.
For those affected by cancer their organization provides helpline and special personal psychosocial support in “Patient support centers” in 6 major oncological institutes in Slovakia. Their volunteers, former patients, are professionally prepared to support newly diagnosed patients in those centers two times per week and mostly discuss psychological problems, social issues, treatment, side effects and nutrition after diagnosis. Their patient support centers on youtube.
Currently, the organization is launching a huge campaign to demand modern treatments for cancer in Slovakia and call for prevention and early detection, including famous sport stars and influencers.
For more activities please see their channel here.
By partnering with WPCC, NIE RAKOVINE can gain access to broader international networks, technical expertise, and funding opportunities to expand its reach, accelerate innovative campaigns, and advocate for equitable access to modern oncology care. They hope that in the future they can participate in international projects via WPCC.
Over the next year, they look forward to strengthening collaboration with WPCC to implement new patient support programs and awareness tools, and influence national health policy to secure timely access to advanced cancer treatments.
